Purchase Order 36C26025P0452
Award Date
2/20/25
Potential Completion Date
3/20/25
Potential Value
$17K
Federal Agency
Veterans Integrated Service Network 20
Awardee
Profounda Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Orlando, FL 32824, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The contract, valued at $49,950.00, is for the delivery of Impavido/Miltefosine, a critical medication used to treat leishmaniasis and other drug-resistant infections, to VA medical centers within the Veterans Integrated Service Network 20 (VISN 20). Profounda Inc. holds a...
This is a firm fixed-price purchase order award to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products, for the delivery of Impavido/Miltefosine capsules and tablets. The award, valued at $99,900.00, was made by the Veterans Integrated Service Network 20 (VISN 20), a division of the U.S. Department of Veterans Affairs (VA). Profounda Inc. specializes in producing and distributing this critical medication used to treat leishmaniasis and...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 23 to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The $49,950.00 contract is for the delivery of the emergency medication miltefosine (Impavido) to the Minneapolis VA Medical Center. Profounda Inc. has a significant Blanket Purchase Agreement (BPA) with VISN 8 to provide miltefosine on a...
This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The contract, valued at $96,000.00, is for the delivery of Impavido/Miltefosine, a critical medication used to treat leishmaniasis and other drug-resistant infections, with a focus on providing emergency pharmaceutical solutions to veterans. Profounda Inc. has a...
The Department of Veterans Affairs' Veterans Health Administration awarded a firm fixed-price purchase order to Profounda Inc., a self-certified small disadvantaged business, to provide Miltefosine drug with a potential value of $149,950.00. The order, placed under the VHA's Veterans Integrated Service Network 23, supports the agency's mission to deliver healthcare services to veterans by ensuring access to this specialized pharmaceutical product needed for treatment. Profounda has previously...
The Department of Veterans Affairs Veterans Health Administration has awarded a firm fixed-price purchase order to Profounda Inc., a self-certified small disadvantaged business and manufacturer, for the delivery of Emergency Patient Profounda Miltefosine Dose Packs. The $16,650 contract has an April 30, 2024 completion date and supports the VHA's mission to provide healthcare services to veterans by ensuring access to this specialty pharmaceutical product. Profounda has previously received...
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration awarded a $299,700.00 firm fixed-price purchase order to Profounda Inc., a self-certified small disadvantaged business manufacturer of pharmaceutical products, to provide the medication Impavido (miltefosine) to the Puget Sound VA Medical Center. This sole-source procurement is to acquire this specialized drug for treating Disseminated Cutaneous Acanthamboeba, with a performance period from May 1, 2025, to October 30,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a $16,750 purchase order to Profounda Inc. for the delivery of 50mg miltefosine capsules. The firm fixed price contract runs from December 14, 2023 through January 13, 2024 and will be performed in Omaha, Nebraska. Profounda Inc. will provide the pharmaceutical products to VA-VHA under this contract to support their healthcare services for veterans. No subcontractors or set aside...
Profounda Inc. was awarded a $50,050 purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 to provide emergency medication Impavidio/Miltefosine for the Minneapolis VA Medical Center. The firm fixed price contract runs from October 5, 2023 through October 19, 2023 and will be performed by Profounda Inc.'s Orlando, Florida division. No subcontractors or set aside designations were identified. The award supports the Veterans...
This federal contract award is for the delivery of pharmaceutical products to the U.S. Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 6 (VISN 6). The prime contractor, United Therapeutics Corp, is a self-certified small disadvantaged business and for-profit manufacturer of pharmaceutical goods. The contract, valued at $90,364.00, is a delivery order placed against United Therapeutics' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. It...